UM Miller School of Medicine: Fighting Osteosarcoma With Leading-Edge Insights and Personalized Care
September 12, 2025
September 12, 2025
MIAMI, Florida, Sept. 12 (TNSjou) -- The University of Miami Miller School of Medicine issued the following news:
* * *
Fighting Osteosarcoma with Leading-Edge Insights and Personalized Care
Summary
* Dr. Emanuela Palmerini is using genetic and immune signatures to advance more precise treatment strategies for osteosarcoma.
* Only one new drug has been approved for osteosarcoma in the past several decades, mifamurtide. Dr. Palmerin . . .
* * *
Fighting Osteosarcoma with Leading-Edge Insights and Personalized Care
Summary
* Dr. Emanuela Palmerini is using genetic and immune signatures to advance more precise treatment strategies for osteosarcoma.
* Only one new drug has been approved for osteosarcoma in the past several decades, mifamurtide. Dr. Palmerin . . .